Skip to main content
editorial
. 2015 Jul 17;6(21):18244–18245. doi: 10.18632/oncotarget.4892

Figure 1. Schematic diagram showing the roles of IL-17 signaling in pancreatic cancer and blockade of the signal by antibodies as a potential treatment.

Figure 1